Download PDF
Zentralbl Chir 2013; 138(6): 636-642
DOI: 10.1055/s-0031-1271601
Übersicht
Georg Thieme Verlag KG Stuttgart · New York

Leberparameter in der Intensivmedizin

Liver Parameters in Intensive Care Medicine
V. Penndorf
1   Universitätsklinikum Essen, Abteilung für Gastroenterologie und Hepatologie, Essen, Deutschland
,
F. Saner
2   Universitätsklinikum Essen, Abteilung für Allgemein-, Viszeral- und Transplantationschirurgie, Essen, Deutschland
,
G. Gerken
1   Universitätsklinikum Essen, Abteilung für Gastroenterologie und Hepatologie, Essen, Deutschland
,
A. Canbay
1   Universitätsklinikum Essen, Abteilung für Gastroenterologie und Hepatologie, Essen, Deutschland
› Author Affiliations
Further Information

Publication History

Publication Date:
07 May 2012 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Leberwerterhöhungen sind bei intensivmedizinischen Patienten mit einer erhöhten Mortalität asso­ziiert. Neben chronischen Lebererkrankungen sind vor allem akute und iatrogene Ereignisse häufige Ursachen von Leberwerterhöhungen auf der Intensivstation. Zur Ursachenfindung empfiehlt sich die Bestimmung von Parametern der Leberzellintegrität (GPT, GOT und GLDH), der Cholestase (AP, GGT und Bilirubin) und der Synthesefunktion (INR und Albumin). Die Sonografie stellt ein kostengünstiges und schnell verfügbares bildgebendes Verfahren zur Diagnostik eines chronischen Leberparenchymschadens, zur Überprüfung der Perfusion sowie zur Detektion von raumfordernden Prozessen oder einer extra­hepatischen Cholestase dar. Ergänzend liefert die transiente Elastografie wichtige Informationen bezüglich einer vorbestehenden chronischen Lebererkrankung. Bei der Interpretation der Befunde ist stets die vorherige intensivmedizinische Behandlung zu berücksichtigen. Neben den häufigen septischen und ischämischen Schädigungen der Leber nehmen therapieassoziierte Komplikationen durch Medikamententoxizität oder durch parenterale Ernährung eine zentrale Bedeutung ein. Die Therapie besteht hauptsächlich in der korrekten Identifizierung und nach Möglichkeit Behebung der zugrundeliegenden Problematik. 

Abstract

Elevated liver function tests in ICU-bound patients are associated with a greater risk of mor­tality. Chronic liver diseases as well as acute events and complications of therapy are among the causes. The disorder could further be investigated by assessment of liver cell integrity markers (AST, ALT and GLDH), cholestasis parameters ­(bilirubin, GGT, ALP) and liver synthethic function (albumin, coagulation profile). Ultrasound and elastography are cheap and mobile options to evaluate chronic liver disease, cholestasis or perfusion of the liver. The interpretation of the results should include the medical history on the ICU. Liver injury could be due to septic or isch­aemic complications as well as toxic side effects or parenteral nutrition. The main therapeutic option is to identify the cause of the liver dysfuntion and to eliminate it as far as possible. 

Schlüsselwörter

Intensivmedizin - Leberchirurgie - OP-Management

Key words

intensive care medicine - liver surgery - surgical strategy
 

  • Literatur

  • Thomson SJ, Cowan ML, Johnston I et al. “Liver function tests” on the intensive care unit: a prospective, observational study. Intensive Care Med 2009; 35: 1406-1411
    CrossrefPubMedGoogle Scholar
  • Brienza N, Dalfino L, Cinnella G et al. Jaundice in critical illness: promoting factors of a concealed reality. Intensive Care Med 2006; 32: 267-274
    CrossrefPubMedGoogle Scholar
  • Kramer L, Jordan B, Druml W et al. Incidence and prognosis of early hepatic dysfunction in critically ill patients – a prospective multicenter study. Crit Care Med 2007; 35: 1099-1104
    CrossrefPubMedGoogle Scholar
  • Zhai R, Sheu CC, Su L et al. Serum bilirubin levels on ICU admission are associated with ARDS development and mortality in sepsis. Thorax 2009; 64: 784-790
    CrossrefPubMedGoogle Scholar
  • Schmidt ES, Schmidt FW. Glutamate dehydrogenase: biochemical and clinical aspects of an interesting enzyme. Clin Chim Acta 1988; 173: 43-55
    CrossrefPubMedGoogle Scholar
  • Fevery J. Bilirubin in clinical practice: a review. Liver Int 2008; 28: 592-605
    CrossrefPubMedGoogle Scholar
  • Schmidt E, Schmidt FW. [Diagnosis of icterus]. Dtsch Med Wochenschr 1984; 109: 139-144
    Article in Thieme ConnectPubMedGoogle Scholar
  • Allan R, Thoirs K, Phillips M. Accuracy of ultrasound to identify chronic liver disease. World J Gastroenterol 2010; 16: 3510-3520
    CrossrefPubMedGoogle Scholar
  • Nishiura T, Watanabe H, Ito M et al. Ultrasound evaluation of the fibrosis stage in chronic liver disease by the simultaneous use of low and high frequency probes. Br J Radiol 2005; 78: 189-197
    CrossrefPubMedGoogle Scholar
  • Ziol M, Handra-Luca A, Kettaneh A et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41: 48-54
    CrossrefPubMedGoogle Scholar
  • Dechêne A, Sowa JP, Gieseler RK et al. Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation. Hepatology 2010; 52: 1008-1016
    CrossrefPubMedGoogle Scholar
  • Wong VW, Chan HL. Transient elastography. J Gastroenterol Hepatol 2010; 25: 1726-1731
    CrossrefPubMedGoogle Scholar
  • Millonig G, Friedrich S, Adolf S et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol 2010; 52: 206-210
    CrossrefPubMedGoogle Scholar
  • Heise M, Jandt K, Rauchfuss F et al. Management von Komplikationen nach Leberresektionen. Zentralbl Chir 2010; 135: 112-120
    Article in Thieme ConnectPubMedGoogle Scholar
  • Go HLS, Baarslag HJ, Vermeulen H et al. A comparative study to validate the use of ultrasonography and computed tomography in patients with post-operative intra-abdominal sepsis. Eur J Radiol 2005; 54: 383-387
    CrossrefPubMedGoogle Scholar
  • Grünhage F, Fischer HP, Sauerbruch T et al. [Drug- and toxin-induced hepatotoxicity]. Z Gastroenterol 2003; 41: 565-578
    Article in Thieme ConnectPubMedGoogle Scholar
  • Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med 2006; 354: 731-739
    CrossrefPubMedGoogle Scholar
  • Temple R. Hy‘s law: predicting serious hepatotoxicity. Pharmacoepidemiol Drug Saf 2006; 15: 241-243
    CrossrefPubMedGoogle Scholar
  • Gorski E, Esterly JS, Postelnick M et al. Evaluation of Hepatotoxicity with Off-Label Oral-Treatment Doses of Voriconazole for Invasive Fungal Infections. Antimicrob Agents Chemother 2011; 55: 184-189
    CrossrefPubMedGoogle Scholar
  • Lutsar I, Hodges MR, Tomaszewski K et al. Safety of voriconazole and dose individualization. Clin Infect Dis 2003; 36: 1087-1088
    CrossrefPubMedGoogle Scholar
  • Wree A, Dechêne A, Herzer K et al. Steroid and Ursodesoxycholic Acid Combination Therapy in Severe Drug-Induced Liver Injury. Digestion 2011; 84: 54-59
    CrossrefPubMedGoogle Scholar
  • Kneiseler G, Herzer K, Marggraf G et al. Die Interaktion zwischen Leber und Herz. Z Herz-Thorax-Gefäßchir 2010; 24: 334-340
    PubMedGoogle Scholar
  • Brahm J, Brahm M, Segovia R et al. Acute and fulminant hepatitis induced by flutamide: Case series report and review of the literature. Ann Hepatol 2011; 10: 93-98
    PubMedGoogle Scholar
  • Saner FH, Heuer M, Meyer M et al. When the heart kills the liver: acute liver failure in congestive heart failure. Eur J Med Res 2009; 14: 541-546
    PubMedGoogle Scholar
  • Fuhrmann V, Kneidinger N, Herkner H et al. Hypoxic hepatitis: under­lying conditions and risk factors for mortality in critically ill patients. Intensive Care Med 2009; 35: 1397-1405
    CrossrefPubMedGoogle Scholar
  • Henrion J, Schapira M, Luwaert R et al. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine (Baltimore) 2003; 82: 392-406
    CrossrefPubMedGoogle Scholar
  • Ring A, Stremmel W. The hepatic microvascular responses to sepsis. Semin Thromb Hemost 2000; 26: 589-594
    Article in Thieme ConnectPubMedGoogle Scholar
  • Ebert EC. Hypoxic liver injury. Mayo Clin Proc 2006; 81: 1232-1236
    CrossrefPubMedGoogle Scholar
  • Fuhrmann V, Jäger B, Zubkova A et al. Hypoxic hepatitis – epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr 2010; 122: 129-139
    CrossrefPubMedGoogle Scholar
  • Koskinas J, Gomatos IP, Tiniakos DG et al. Liver histology in ICU patients dying from sepsis: a clinico-pathological study. World J Gastroenterol 2008; 14: 1389-1393
    CrossrefPubMedGoogle Scholar
  • Kredel M, Muellenbach RM, Brock RW et al. Liver dysfunction after lung recruitment manoeuvres during pressure-controlled ventilation in experimental acute respiratory distress. Crit Care 2007; 11: R13
    CrossrefPubMedGoogle Scholar
  • Berendes E, Lippert G, Loick HM et al. Effects of positive end-expiratory pressure ventilation on splanchnic oxygenation in humans. J Cardiothorac Vasc Anesth 1996; 10: 598-602
    CrossrefPubMedGoogle Scholar
  • Kocabayoglu P, Treckmann JW, Beckebaum S et al. Does long-term ventilation with PEEP > or = 10 mbar influence graft-function in patients following liver transplantation?. Hepatogastroenterology 2010; 57: 839-844
    PubMedGoogle Scholar
  • Grau T, Bonet A, Rubio M et al. Liver dysfunction associated with artificial nutrition in critically ill patients. Crit Care 2007; 11: R10
    CrossrefPubMedGoogle Scholar
  • Nolan JP. The role of intestinal endotoxin in liver injury: a long and evolving history. Hepatology 2010; 52: 1829-1835
    CrossrefPubMedGoogle Scholar
  • Dechêne A, Kaiser G, Paul A et al. Gastrointestinale Komplikationen nach kardiochirurgischen Operationen. Z Herz-Thorax-Gefäßchir 2009; 24: 28-36
    PubMedGoogle Scholar
  • Utzolino S, Hopt UT, Kaffarnik M. Die postoperative Sepsis: Diagnose, Besonderheiten, Management. Zentralbl Chir 2010; 135: 240-248
    Article in Thieme ConnectPubMedGoogle Scholar
  • Geier A, Fickert P, Trauner M. Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 574-585
    CrossrefPubMedGoogle Scholar
  • Wagner M, Zollner G, Trauner M. Ischemia and cholestasis: more than (just) the bile ducts!. Transplantation 2008; 85: 1083-1085
    CrossrefPubMedGoogle Scholar